Jamie Gregorian focuses his practice on the representation of corporations and associations before Congress, the Administration, and federal agencies, with a concentration on healthcare and the life sciences. He also advises clients on congressional strategies and the legislative process.
For the last six years, Jamie served as Senior Director, Federal Government Relations at the Biotechnology Innovation Organization (BIO). As the principal trade association for over 1,000 biotechnology companies, universities, and state-based biotech organizations, Jamie’s work at BIO was at the forefront of the life sciences industry’s lobbying efforts before Congress and the executive branch. He led fights on issues surrounding drug pricing, drug development, 340B reforms, vaccines, and antimicrobial resistance, among others. Jamie successfully organized Democratic Congressional opposition to the Obama administration’s attempt to reduce Medicare Part B reimbursements.
Prior to joining BIO, Jamie served five years as a lobbyist for the American Academy of Orthopaedic Surgeons (AAOS). At AAOS, Jamie led the organization’s efforts on reimbursement, research funding, appropriations, and antitrust. Jamie secured over $100 million in funding for Department of Defense programs to help salvage the limbs of wounded warriors, allowing them to return to full function and duty. He worked alongside former House Judiciary Chairman John Conyers (D-MI) to reform antitrust laws affecting the healthcare industry, culminating recently in the repeal of health insurers’ antitrust exemptions in the McCarran-Ferguson Act.
DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.
Unsolicited e-mails and information sent to DLA Piper or the independent DLA Piper Relationship firms will not be considered confidential, may be disclosed to others, may not receive a response, and do not create a lawyer-client relationship with DLA Piper or any of the DLA Piper Relationship firms. Please do not include any confidential information in this message. Also, please note that our lawyers do not seek to practice law in any jurisdiction in which they are not properly permitted to do so.